Search Result "PARP-1 inhibitors"
Poly(ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors in Cancer Chemotherapy
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 1 Issue: 1 Year: 2006 Page: 39-53
Author(s): Victoria Cepeda, Miguel A. Fuertes, Josefina Castilla, Carlos Alonso, Celia Quevedo, Manual Soto, Jose M. Perez
Recent Progress in the Research on Benzimidazole PARP-1 Inhibitors
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 22 Issue: 19 Year: 2022 Page: 2438-2462
Author(s):
Synthetic PARP-1 Inhibitors Reported During the Last Decade
Journal: Letters in Drug Design & Discovery
Volume: 20 Issue: 7 Year: 2023 Page: 793-807
Author(s):
Methods of PARP-1 Determination and its Importance in LivingOrganisms
Journal: Protein & Peptide Letters
Volume: 29 Issue: 6 Year: 2022 Page: 496-504
Author(s):
Synthesis and In silico Studies of Quinazolinone Derivatives as PARP-1 Inhibitors
Journal: Letters in Drug Design & Discovery
Volume: 17 Issue: 12 Year: 2020 Page: 1552-1565
Author(s): Sonia Verma,Akashdeep Singh Pathania,Somesh Baranwal,Pradeep Kumar
Synthesis and In Silico Studies of Quinazolinones as PARP-1 Inhibitors
Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 27 Issue: 9 Year: 2024 Page: 1329-1343
Author(s): Ankit Kumar Singh
Design and Synthesis of Benzimidazole-4-carboxamides as Potent Poly(ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors
Journal: Current Bioactive Compounds
Volume: 14 Issue: 2 Year: 2018 Page: 100-111
Author(s): Kalam B. Reddy,Gangula M. Rao,Baru V. Kumar,Chinmayee Choudhury,Kombu S. Rajan
Oxidative DNA Damage-induced PARP-1-mediated Autophagic FluxDisruption Contributes to Bupivacaine-induced Neurotoxicity DuringPregnancy
Journal: Current Neuropharmacology
Volume: 21 Issue: 10 Year: 2023 Page: 2134-2150
Author(s):
PARP Inhibitor Development for Systemic Cancer Targeting
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 7 Issue: 5 Year: 2007 Page: 515-523
Author(s): Tomasz Zaremba, Nicola Jane Curtin
Pharmacological Inhibition of Poly(ADP-ribose) Polymerase (PARP) Activity in PARP-1 Silenced Tumour Cells Increases Chemosensitivity to Temozolomide and to a N3-Adenine Selective Methylating Agent
Journal: Current Cancer Drug Targets
Volume: 10 Issue: 4 Year: 2010 Page: 368-383
Author(s): L. Tentori, A. Muzi, A.S. Dorio, M. Scarsella, C. Leonetti, G.M. Shah, W. Xu, E. Camaioni, B. Gold, R. Pellicciari, F. Dantzer, J. Zhang, G. Graziani